The ALS Association and the city of Orlando, Fla., are proud to be selected by the Motor Neurone Disease Association to host the prestigious 21st International Symposium on ALS/MND. We look forward to welcoming you to this very important gathering where experts in both the scientific and clinical fields will share their latest findings in ALS research. Many of those that we will be greeting are researchers that we have collaborated with for many years as part of our global research program. The findings at the Symposium and synergy that is created by everyone working closely together are bringing us nearer to achieving our goal of discovering new treatments and a cure. It is encouraging to know that the participants at the Symposium share this passion. The ALS Association is commemorating its 25th anniversary this year as a leader in the fight against ALS. Our message to the people with ALS and the families we help is that together we are entering an exciting new era with a renewed sense of enthusiasm that new breakthroughs in ALS research are on the horizon. This enthusiasm is reinforced by the discoveries reported each year at the Symposium. During the Symposium, staff and volunteers from the ALS Association Florida Chapter will be available to direct you to sessions and answer your questions. Just look for the friendly people wearing T-shirts with the ALSAssociation big red “A” logo and the Symposium logo. When making your travel arrangements, plan to arrive a few days early and stay an extra few days after the Symposium to take advantage of the fun-filled activities Orlando has to offer. The city has sunny days with an average temperature of 22.7C (73F) in December and is well known for its theme parks, arts and entertainment, music, sporting events, dining, shopping and beaches. (Source: MND Association, http://www.mndassociation.org/index.html)
ALSTDI Talks: Continuousnon-invasive infrared motion sensing as a measure of neurological diseaseprogression in the SOD1-G93A transgenic mouse model of ALS (Harveen Dhillon, Ph.D.) A high throughputimage analysis strategy for analysis of in situ hybridization transcriptpatterns in the SOD1_G93A mouse model of ALS (John Lincecum, Ph.D.) Pharmacodynamicbiomarkers of immunomodulatory therapies in the mouse models of ALS (Steve Perrin, Ph.D.) No benefit fromchronic dimebolin dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS (Fernando G. Vieira, M.D.) Understandingthe role of macrophage and Schwann cells in peripheral nerves of the SOD1 mousemodel of ALS(Monica Wang) |